CAMP Reports $109.5M Cash, $80.4M Net Loss, $17.5M GSK Upfront, $100M Placement, $30M Offering, $50M Buyback Potential, $19.3M EPS, +94% YoY
CAMP4 Therapeutics Corporation Common Stock · PHARMACEUTICAL PREPARATIONS · Now $4.04
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS